Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Board Changes

3 Dec 2007 07:00

Gleeson(M J)Group PLC03 December 2007 Monday 3 December 2007 M J GLEESON GROUP PLC Board Changes Gleeson (GLE.L), the house-builder specialising in urban regeneration, ispleased to announce the appointment as a non-executive Director, with immediateeffect, of Colin Dearlove, formerly Group Finance Director of BarrattDevelopments plc, a FTSE 100 company. Colin Dearlove will replace Eric Stobart, who will retire from the Board on 31January 2008, at the conclusion of three three-year terms (the limit forcorporate governance considerations of independence). Colin Dearlove, BA, FCMA, aged 56, was at Barratt Developments, theNewcastle-based national house-builder, from 1981 to 2006, as Group ChiefAccountant from 1985 to 1992 and as Group Finance Director from 1992 to 2006. Save as disclosed above, Colin Dearlove has held no directorship in any otherpublicly quoted company at any time during the previous five years and thereare no details to be disclosed by Mr Dearlove under paragraph 9.6.13R of the Listing Rules. Welcoming Colin Dearlove to the Gleeson Board, Dermot Gleeson, Chairman, stated"My Board colleagues and I are delighted that someone of Colin's standing in thehouse-building industry is joining our Board. His considerable experience atBarratt Developments of implementing strategic change, and knowledge of the UKhousing market, particularly in the North of England, where much of Gleeson'sRegeneration business is located, are also major plusses." Thanking Eric Stobart for his contribution to the Gleeson Board, Dermot Gleesonstated "Eric Stobart, who has chaired the Audit Committee since 1999, has been atruly exceptional colleague. He has a huge depth of financial knowledge and hasproved to be an immensely wise and unflappable adviser. The Group owes him anenormous debt of gratitude" Notes for Editors: Following Colin Dearlove's appointment and Eric Stobart's retirement, theGleeson Board of Directors will comprise six members. Two are executive - PaulWallwork (Group Chief Executive) and Chris Holt (Group Finance Director) - andfour are non-executive - Dermot Gleeson (Chairman), Ross Ancell, Colin Dearloveand Terry Morgan. Enquiries: M J Gleeson Group plc 01252-360 300 Dermot Gleeson (Chairman)Paul Wallwork (Group Chief Executive) Bankside ConsultantsCharles Ponsonby 020-7367 8851 Photographs: Photographs of Colin Dearlove and Eric Stobart are available from Rose Oddy ofBankside Consultants at rose.oddy@bankside.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Feb 20254:14 pmRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSResults for the half year ended 31 December 2024
7th Feb 202511:51 amRNSDirector/PDMR Shareholding
14th Jan 20257:00 amRNSTrading Update & Notice of Results
7th Jan 20254:28 pmRNSDirector/PDMR Shareholding
9th Dec 20244:59 pmRNSDirector/PDMR Shareholding
3rd Dec 20243:50 pmRNSDirector/PDMR Shareholding
26th Nov 20243:34 pmRNSDirector/PDMR Shareholding
15th Nov 20242:08 pmRNSResult of AGM
15th Nov 20247:00 amRNSAGM Trading Update
7th Nov 20242:44 pmRNSDirector/PDMR Shareholding
30th Oct 202410:42 amRNSDirector/PDMR Shareholding
21st Oct 20247:00 amRNSNotice of AGM
18th Oct 20244:24 pmRNSDirector/PDMR Shareholding
18th Oct 20244:19 pmRNSDirector/PDMR Shareholding
9th Oct 20244:27 pmRNSDirector/PDMR Shareholding
4th Oct 202410:18 amRNSDirector/PDMR Shareholding
30th Sep 20247:00 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSAudited results for the year ended 30 June 2024
9th Sep 202410:18 amRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSTotal Voting Rights
7th Aug 20249:41 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSTotal Voting Rights
23rd Jul 20242:36 pmRNSDirector/PDMR Shareholding
23rd Jul 20241:53 pmRNSStandard form for notification of major holdings
11th Jul 20247:00 amRNSFY2024 Trading Update
8th Jul 20241:34 pmRNSDirector/PDMR Shareholding
8th Jul 20247:00 amRNSNotice of Trading Update
28th Jun 20247:00 amRNSTotal Voting Rights
6th Jun 20242:46 pmRNSDirector/PDMR Shareholding
31st May 20247:00 amRNSTotal Voting Rights
15th May 20247:00 amRNSAppointment of Joint Corporate Broker
9th May 20249:41 amRNSDirector/PDMR Shareholding
30th Apr 20247:00 amRNSTotal Voting Rights
8th Apr 20243:41 pmRNSDirector/PDMR Shareholding
3rd Apr 20244:28 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:28 pmRNSDirector/PDMR Shareholding
28th Mar 20247:00 amRNSTotal Voting Rights
22nd Mar 20249:07 amRNSDirector/PDMR Shareholding
20th Mar 20241:45 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSTotal Voting Rights
26th Feb 20241:04 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSResults for the half year ended 31 December 2023
7th Feb 202411:34 amRNSDirector/PDMR Shareholding
31st Jan 20247:00 amRNSTotal Voting Rights
9th Jan 202410:50 amRNSDirector/PDMR Shareholding
9th Jan 20247:00 amRNSTrading Update & Notice of Results
29th Dec 20237:00 amRNSTotal Voting Rights
15th Dec 20232:49 pmRNSRe Directorate External Appointments
6th Dec 20234:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.